K. P. Johnson - Concepedia

Author

K. P. Johnson

University of Maryland, Baltimore

Also Known As

K Johnson, K P Johnson, K. Johnson, K. P. Johnson, K.P Johnson, K.P. Johnson, Kesha Johnson

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

University of Maryland, Baltimore Wayne State University University of Southern California Karolinska Institutet Yale University

About

K. P. Johnson is an author at University of Maryland, Baltimore specializing in medicine, immunology, and neuroimmunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	1.8K
2	Health Sciences	5	5	462
3	Social Sciences	2	2	822
4	Allergy	2	2	34
5	Nursing	1	1	115

K. P. Johnson

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis K. P. Johnson, Benjamin Brooks, J. A. Cohen, Neurology	1995	1.9K
Tumor necrosis factor identified in multiple sclerosis brain. Florence M. Hofman, David R. Hinton, K. P. Johnson, The Journal of Experimental Medicine Neurological DisorderImmunologySocial SciencesNeuroinflammationInflammation	1989	796
Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years K. P. Johnson, Benjamin Brooks, Corey C. Ford, Multiple Sclerosis Journal	2000	227
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate Corey C. Ford, K. P. Johnson, Norman J. Kachuck, Multiple Sclerosis Journal	2010	206
Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years K. P. Johnson, Benjamin Brooks, Corey C. Ford, Multiple Sclerosis Journal Neurological DisorderImmunologyNeuromodulation TherapiesClinical NeurologyNeurological Progress	2000	188
The effects of 4‐aminopyridine in multiple sclerosis patients C. T. Bever, Douglas Young, Paul A. Anderson, Neurology Neurological DisorderPharmacotherapyTranslational MedicineMultiple Sclerosis PatientsBrain Injury	1994	154
A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients Corey C. Ford, K. P. Johnson, Robert P. Lisak, Multiple Sclerosis Journal	2006	138
The relationship of MS to physical trauma and psychological stress [RETIRED] Douglas S. Goodin, George C. Ebers, K. P. Johnson, Neurology NursingPhysical TraumaPsychiatryStressMental Health	1999	115
Glatiramer acetate induces a Th2-biased response and crossreactivity with myelin basic protein in patients with MS M Chen, Bruno Gran, Kathleen Costello, Multiple Sclerosis Journal	2001	104
Five measles virus antigens demonstrated by use of mouse hybridoma antibodies in productively infected tissue culture cells Erling Norrby, S. -N. Chen, T Togashi, Archives of Virology VaccinationViral ReplicationMedicineImmunologyViral Pathogenesis	1982	87

Page 1